Increased vaccine tolerability and protection via NF-κB modulation | Science Advances
What are CpG ODNs and What is their Purpose? - Synbio Technologies
Amphiphile-CpG vaccination induces potent lymph node activation and COVID-19 immunity in mice and non-human primates | npj Vaccines
CpG-C ODN M362 as an immunoadjuvant for HBV therapeutic vaccine reverses the systemic tolerance against HBV
Phase 1 Trial of AMA1-C1/Alhydrogel plus CPG 7909: An Asexual Blood-Stage Vaccine for Plasmodium falciparum Malaria | PLOS ONE
Human TLR9 Agonist Kit | Stimulatory CpG ODNs | InvivoGen
Biomedicines | Free Full-Text | Toll-Like Receptor 9 Agonists for Cancer Therapy
Toll-like receptor 9 activation by CpG oligodeoxynucleotide 7909 enhances the radiosensitivity of A549 lung cancer cells via the p53 signaling pathway
CpG oligodeoxynucleotide - Wikipedia
Frontiers | Class C CpG Oligodeoxynucleotide Immunomodulatory Response in Aged Squirrel Monkey (Saimiri Boliviensis Boliviensis)
PDF) CPG 7909, an Immunostimulatory TLR9 Agonist Oligodeoxynucleotide, as Adjuvant to Engerix-B� HBV Vaccine in Healthy Adults: A Double-Blind Phase I/II Study
Safety and immunogenicity of CPG 7909 injection as an adjuvant to Fluarix influenza vaccine - ScienceDirect
Phase 1 Trial of AMA1-C1/Alhydrogel plus CPG 7909: An Asexual Blood-Stage Vaccine for Plasmodium falciparum Malaria | PLOS ONE
Therapeutic Applications of Synthetic CpG Oligodeoxynucleotides as TLR9 Agonists for Immune Modulation | SpringerLink
A CpG Oligonucleotide Can Protect Mice from a Low Aerosol Challenge Dose of Burkholderia mallei | Infection and Immunity
Human TLR9 Reporter THP-1 Cells | InvivoGen
Optimization, Production, and Characterization of a CpG-Oligonucleotide-Ficoll Conjugate Nanoparticle Adjuvant for Enhanced Immunogenicity of Anthrax Protective Antigen | Bioconjugate Chemistry
CXCL14 Acts as a Specific Carrier of CpG DNA into Dendritic Cells and Activates Toll-like Receptor 9-mediated Adaptive Immunity - eBioMedicine
Human TLR9 Agonist Kit | Stimulatory CpG ODNs | InvivoGen
Spherical nucleic acids as an infectious disease vaccine platform | PNAS
Frontiers | S-540956, a CpG Oligonucleotide Annealed to a Complementary Strand With an Amphiphilic Chain Unit, Acts as a Potent Cancer Vaccine Adjuvant by Targeting Draining Lymph Nodes
Full article: CPG-7909 (PF-3512676, ProMune®): toll-like receptor-9 agonist in cancer therapy
Synthetic CpG-ODN rapidly enriches immune compartments in neonatal chicks to induce protective immunity against bacterial infections | Scientific Reports
